MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2017 International Congress

    The prevalence of cerebral microbleeds in patients with Parkinson’s disease and multiple system atrophy

    J.-M. Kim (Seongnam, Republic of Korea)

    Objective: Here, we compared the prevalence of cerebral microbleeds (CMBs) in patients with parkinsonian disorders, including Parkinson’s diseaseParkinson’s disease (PD) and multiple system atrophy (MSA).…
  • 2017 International Congress

    Parkinson’s disease with visual hallucination: optic radiation abnormalities on phase difference-enhanced imaging (PADRE)

    M. Miyata, S. Kakeda, T. Yoneda, H. Narimatsu, T. Sato, K. Okada, H. Adachi, Y. Korogi (Kitakyushu, Japan)

    Objective: We assessed structural abnormalities of optic radiation (OR) in patients with Parkinson disease (PD) with dementia (PDD) and dementia with lewy bodies (DLB) by…
  • 2017 International Congress

    Hypertension and Parkinson’s disease

    B. Giordano, G. Pagano, J. Hood, N. Ferrara, M. Politis (London, United Kingdom)

    Objective: To compared clinical burden, neuropsychological features, CSF and imaging pathology in early untreated PD patients with and without HT. Background: Hypertension (HT) has been…
  • 2017 International Congress

    The role of phosphodiesterase 4 in sleep disturbances in Parkinson’s disease

    H. Wilson, G. Pagano, F. Niccolini, N. Muhlert, C. Coello, M. Mehta, G. Searle, R. Gunn, E. Rabiner, T. Foltynie, M. Politis (London, United Kingdom)

    Objective: We aimed to assess the association between phosphodiesterase 4 (PDE4) expression and sleep disturbances in vivo using combined multimodal magnetic resonance imaging (MRI) and…
  • 2017 International Congress

    Assessing cholinergic innervation in Parkinson’s disease using the PET imaging marker [18F]Fluoroethoxybenzovesamicol

    S. vander Zee, I. Alves, A. Willemsen, P. Elsinga, T. van Laar (Groningen, Netherlands)

    Objective: To validate [18F]Fluoroethoxybenzovesamicol ([18F]FEOBV) imaging in healthy volunteers by dynamic scanning. The secondary objective of this study was to evaluate the differences in [18F]FEOBV binding…
  • 2017 International Congress

    High-Pass Filtered Phase MR Imaging to Detect Longitudinal Motor Associations of Iron Accumulation in Parkinson’s Disease

    A. Martin-Bastida, N. Lao-Kaim, Y. Xing, C. Loane, A. Roussakis, S. Schwarz, N. Valle-Guzman, P. Mahlknecht, X. Li, G. Paul-Visse, H. Widner, M. Politis, T. Foltynie, R. Barker, D. Auer, P. Piccini (London, United Kingdom)

    Objective: To assess whether longitudinal changes in deep grey matter nuclei iron content are associated with declining motor function in Parkinson’s disease over a period…
  • 2017 International Congress

    Altered PDE10A Expression Detectable Early in Untreated Parkinson’s Disease Patients

    G. Pagano, F. Niccolini, H. Wilson, T. Yousaf, N. Khan, D. Martino, R. Gunn, E. Rabiner, M. Politis (London, United Kingdom)

    Objective: To investigate in vivo whether loss of PDE10A expression in Parkinson’s disease (PD) is an early phenomenon in early untreated PD patients using positron…
  • 2017 International Congress

    Clinical characteristics of cognitive impairment in patients with Parkinson’s disease and its related pattern in 18F-FDG PET imaging

    F.-t. Liu, J.-j. Ge, L. Wu, Y.-j. Yang, J. Zhao, S.-s. Luo, Y.-m. Sun, J.-j. Wu, Z.-t. Ding, C.-t. Zuo, J. Wang (Shanghai, China)

    Objective: To characterize the clinical features and the neuroanatomical bases of cognitive impairment in Parkinson’s disease (PD) with respect to attention, executive function, memory, language,…
  • 2017 International Congress

    Assessing Nigral Functional Connectivity in Parkinson’s Disease with Resting State Functional MRI

    A. Martin-Bastida, Y. Xing, S. Pietracupa, A. Roussakis, N. Lao-Kaim, W. Li, X. Li, P. Mahlknecht, S. Schwarz, T. Foltynie, D. Auer, P. Piccini (London, United Kingdom)

    Objective: To evaluate functional connectivity of SN with basal ganglia and motor cortex in Parkinson’s disease (PD) using resting state functional MRI (RS fMRI). Background:…
  • 2017 International Congress

    Impacts of White Matter Hyperintensities on Limit of Stability in Drug-naïve, de novo Patients with Idiopathic Parkinson’s Disease

    J.-H. Park, S.-K. Lee, T.-K. Lee (Bucheon-si, Republic of Korea)

    Objective: The aims of this study were to investigate the effects of incidental white matter hyperintensities(WMH) on self-initiated postural control in drug-naïve, newly diagnosed Parkinson disease…
  • « Previous Page
  • 1
  • …
  • 1522
  • 1523
  • 1524
  • 1525
  • 1526
  • …
  • 1734
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley